 |
FDA Approval Activities for this Drug
Keppra (levetiracetam) Solution, UCB Pharma NDA 21-505 7/15/03 7/28/03
Keppra (levetiracetam) Tablets, UCB Pharma, NDA 21-035/S30 9/3/03 9/9/03
Keppra (levetiracetam) Tablets, UCB Pharma, NDA 21-035/S13 & S19 5/22/02 5/29/02
Keppra (levetiracetam) Tablets, 250 mg, 500 mg, and 750 mg. UCB Pharma, NDA 21-035 | Keppra (levetiracetam) Tablets, UCB Pharma, Inc., Labeling Revision
| Keppra (levetiracetam) Oral Solution, UCB Pharma, Inc., Labeling Revision
For the latest approval information, please locate this drug using this index.
|